We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Mary-Ann Fitzcharles

Mary-Ann Fitzcharles MD

Alan Edwards Pain Management Unit, McGill University Health Center, Montreal, Canada; Division of Rheumatology, McGill University Health Centre, Quebec, Canada

Mary-Ann Fitzcharles is a clinician, teacher and clinical researcher at McGill University, Montreal, Canada since 1982. Medical school was at University Cape Town, South Africa, rheumatology training was at the London Hospital, England. Career interest has focused on rheumatic disease pain, and she has served on national/international committees in this context. She is a founder member of the Royal College of Physicians and Surgeons of Canada specialty committee for Pain Medicine, is an immediate past chair of the Canadian Rheumatology Association (CRA) Therapeutics Committee and has led the 2012 Canadian fibromyalgia guideline group and the CRA position statement on medical cannabis. Recent publications and national/international presentations have addressed the concept of pain associated with rheumatic diseases and the use of opioids and cannabinoids in rheumatology patients.